ALPX
ALPXCIK 0002125551
Small by assets
Assets $116M
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
10-Q
Filed Aug 13, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Jul 2, 2026
· Period ending Jun 26, 2026
Summary not yet generated.
Partner
Trade ALPX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Jun 30, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Jun 29, 2026
· Period ending Jun 24, 2026
Summary not yet generated.
S-1/A
Filed Jun 5, 2026
Critical
ALPX, a blank-check company, files S-1/A for $100M SPAC IPO at $10 per unit
5 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Aug 13, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | period from January 5, 2026 (inception) through June 30, 2026 |
|---|---|---|
| Formation and operating costs | (157,028) | (216,884) |
| Total Operating Loss | (157,028) | (216,884) |
| Interest income on cash and cash equivalents | 1,270 | 1,270 |
| Interest income on marketable securities held in trust account | 32,370 | 32,370 |
| Net Loss | (123,388) | (183,244) |
| Basic and diluted weighted-average shares outstanding, Class A ordinary shares subject to possible redemption | 631,868 | 324,859 |
| Basic and diluted net loss per share, Class A ordinary shares subject to possible redemption | (0.04) | (0.06) |
| Basic and diluted weighted-average shares outstanding, non-redeemable Class A ordinary shares | 22,940 | 11,794 |
| Basic and diluted net loss per share, non-redeemable Class A ordinary shares | (0.04) | (0.06) |
| Basic weighted-average shares outstanding, non-redeemable Class B ordinary shares (1) | 2,520,604 | 2,510,593 |
| Basic net loss per share, non-redeemable Class B ordinary shares | (0.04) | (0.06) |
| Diluted weighted-average shares outstanding, non-redeemable Class B ordinary shares | 2,875,000 | 2,875,000 |
| Diluted net loss per share, non-redeemable Class B ordinary shares | (0.03) | (0.06) |
Condensed Balance Sheets
| Description | As of June 30, 2026 (Unaudited) | As of March 15, 2026 (Audited) |
|---|---|---|
| Cash and cash equivalents | 754,952 | - |
| Prepaid expenses | 120,000 | - |
| Deferred offering costs | - | 117,000 |
| Total current assets | 874,952 | 117,000 |
| Cash and marketable securities held in trust account | 115,032,370 | - |
| Total assets | 115,907,322 | 117,000 |
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accrued expenses and other current liabilities | 18,959 | - |
| Promissory note related party | 219,028 | 170,102 |
| Total current liabilities | 237,987 | 170,102 |
| Deferred underwriting fee payable | 805,000 | - |
| Total liabilities | 1,042,987 | 170,102 |
| Commitments and Contingencies | ||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 11,500,000 shares at initial redemption value of $10.00 per share, as adjusted for Trust Account earnings | 115,032,370 | - |
| Shareholders’ Deficit: | ||
| Preferred shares, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding | - | - |
| Class A ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 417,500 and no shares issued and outstanding (excluding redeemable shares), respectively(1) | 42 | - |
| Class B ordinary shares, $0.0001 par value; 90,000,000 shares authorized; 2,875,000 shares issued and outstanding(2) | 288 | 288 |
| Additional paid-in capital | 14,879 | 24,712 |
| Share subscription receivable | - | (25,000) |
| Accumulated deficit | (183,244) | (53,102) |
| Total Shareholders’ Deficit | (168,035) | (53,102) |
| Total Liabilities and Shareholders’ Deficit | 115,907,322 | 117,000 |
Condensed Statements of Cash Flows (Unaudited)
| Description | period from January 5, 2026 (inception) through June 30, 2026 |
|---|---|
| Cash Flows from Operating Activities: | |
| Net loss | (183,244) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Formation and operating costs paid by Sponsor | 92,925 |
| Deferred offering cost written off to expense | 5,000 |
| Income earned on cash and Cash and marketable securities held in trust account | (32,370) |
| Changes in operating assets and liabilities: | |
| Accrued liabilities and other payables | 18,959 |
| Prepaid expenses | (120,000) |
| Net cash used in operating activities | (218,730) |
| Cash Flows from Investing Activities: | |
| Investment of cash in trust account | (115,000,000) |
| Net cash used in investing activities | (115,000,000) |
| Cash Flows from Financing Activities: | |
| Capital contribution from Sponsor | 1,000 |
| Proceeds from public offering | 115,000,000 |
| Cash proceeds from private placement | 1,800,000 |
| Payment of offering costs | (827,318) |
| Net cash provided by financing activities | 115,973,682 |
| Net increase in cash and cash equivalents | 754,952 |
| Cash and cash equivalents at beginning of period | - |
| Cash and cash equivalents at end of period | 754,952 |
| Supplemental disclosure of non-cash financing activities: | |
| Deferred offering costs paid by Sponsor and included in Promissory Note | 226,103 |
| Deferred underwriting fee accrued and charged to additional paid-in capital | 805,000 |
| Private placement and founder share subscription amounts settled against Promissory Note | 100,000 |
| Representative shares issued as non-cash underwriting compensation | 251,713 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗